Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DICK’S SPORTING GOODS, INC. (NYSE: DKS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Dick’s
-
MOBILEYE GLOBAL INC. (NASDAQ: MBLY) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Mobileye Globa
-
DADA NEXUS LIMITED (NASDAQ: DADA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Dada Nexus Limit
-
Acorn, Provider of Remote Monitoring and Control Solutions for Backup Generators, Hosts Q4 Investor Call Thurs., March 7th at 11am ET
-
Benjamin Hill Mining Corp. Announces Private Placement of Units
-
National Association of Home Builders Names Bridgeland® Master Planned Community of the Year for 2024
-
Former Prime Ministers Call For Cultural And Creative Industries To Unleash Their Power To Transform Societies On Opening Day Of The Sixth Edition Of Culture Summit Abu Dhabi, Held Under The Theme ‘
-
Completion of Placement to Zijin Mining
-
Plantify Foods Secures New Retail Chain to Sell Its Plant-Based Clean Label Products
-
Goliath’s Updated Model Confirms Six New Gold Veins for a Total of 10 Demonstrates Increased Tonnage Potential at Surebet Discovery on Golddigger Property, Golden Triangle, British Columbia
-
The Joint Corp. to Participate in the 36th Annual Roth Conference
-
Beamr Issues Annual CEO Letter to Shareholders: Highlighting Beamr Cloud Launch, 2023 Financial Results and Achievements and Q2 2024 Upcoming Milestones
-
Osisko Development Secures US$50 Million Funding to Commence Underground Development at Cariboo Gold Project
-
Ethisphere names Avista as one of the 2024 World’s Most Ethical Companies® for the fifth time
-
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
-
Talisker Intersects 129.99 g/t Au over 2.00 Metres from the Bralorne Gold Project Resource Conversion Program
-
Eloro Resources Amends Payment Schedule for Iska Iska Silver-Tin Polymetallic Project, Potosi Department, Bolivia
-
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
-
Metallurgical Tests at Kharmagtai Show Strong Sulphide Rougher Flotation Recovery
-
Arvinas to Participate in Upcoming Investor Conferences
-
Rivalry to Present at SBC Summit Rio 2024
-
West Red Lake Gold Intersects 25.12 g/t Au over 5.5m, 39.46 g/t Au over 2m and 18.60 g/t Au over 4m at South Austin Zone – Madsen Mine
-
Mirasol Video Update on Sobek Copper-Gold Project – Highlighting the Recent Strategic Addition of Adjacent Rosita Property in Vicuña District, Chile
-
AIP Realty Trust Update on Strategic Review & Engagement of Raymond James
-
United Food and Commercial Workers Canada releases 2023 Annual Report
-
Condor Initiates Gas Field Production Enhancement Operations in the Republic of Uzbekistan
-
Kaixin Auto Holdings Announces Myanmar Order of 1,000 EVs
-
ECARX's Global Expansion Driven by Strong R&D and International Accreditations
-
Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
-
Puma Announces a Creative Deal to Unlock Value of its Assets in New Brunswick
-
Excitement Builds: Aqua-Tots Swim School Now Open in Holland, MI
-
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
-
Notice of Inducement Grants for Kurt Hoff, Lantronix Vice President, Worldwide Sales
-
WalkMe to Present at Upcoming Investor Conference
-
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PG
-
Blackwells Capital Releases Investor Presentation to its Fellow Disney Shareholders
-
Tecnoglass to Attend the Raymond James 45th Annual Institutional Investors Conference
-
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
-
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-ED
-
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
-
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
-
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
-
Verizon Innovative Learning reaches 7 million students nationwide to tackle digital divide
-
MAPLEBEAR INC. (NASDAQ: CART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Maplebear Inc. d/b/a
-
XPONENTIAL FITNESS, INC. (NYSE: XPOF) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Xponential F
-
Velcan Holdings: Share buyback program - weekly statement
-
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
ECARX's Global Expansion Driven by Strong R&D and International Accreditations
-
Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development
-
Ferrari N.V.: Periodic Report on the Buyback Program
